A total of 63 joint ventures with foreign pharmaceutical companies have been set up within China's Zhejiang province.
the drug industry is centered in the provincial capital Hangzhou, where nine foreign drug companies have invested $87.9 million since the beginning of 1995. The province plans to make the drug sector a pillar industry during the Ninth Five-Year Plan period (1996-2000).
In 1994, Merck Sharp & Dohme invested $26 million in a joint venture with a Hangzhou company to set up what the province called the world's largest drug plant; the plant can produce 100 million tablets per year. Sanofi has invested $15 million in setting up a joint venture, and Allergan also invested $29.7 million to open a branch in the provincial capital.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze